Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Multiple-antigen MVA/DNA HIV vaccine regimen is safe and immunogenic in phase I trial

March 9, 2011

Microbicide vaginal gel containing C2F5/C4E10/C2G12 MAbs for HIV-1 is safe in phase I trial

March 9, 2011

AGS-004 delays rebound of HIV during interruption of antiretroviral therapy

March 8, 2011

GS-7340 is more effective than TDF in reducing HIV-1 RNA in patients

March 4, 2011

Anti-HIV antibody response at mucosal sites protects monkeys against infection

March 4, 2011

HGN-194 confers cross-clade protection in model of HIV infection

March 3, 2011

New data presented on anti-HIV agent BMS-626529 and its prodrug BMS-663068

March 3, 2011

HIV reverse transcriptase inhibitors patented by AiCuris

March 2, 2011

Belgian researchers disclose new inhibitors of HIV replication

Feb. 28, 2011

GSK divulges new agents for treatment of HIV infections

Feb. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...